Category NEWS

Abcuro

Abcuro shared Phase 2/3 MUSCLE study results for ulviprubart in inclusion body myositis at GCOM 2026.

Abcuro Presents Results from Phase 2/3 MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis at GCOM 2026 Abcuro, Inc., a clinical stage biotechnology company, today presented results at the 6th Global Conference on Myositis (GCOM) meeting, being held March 23-26, 2026…

Read MoreAbcuro shared Phase 2/3 MUSCLE study results for ulviprubart in inclusion body myositis at GCOM 2026.
Major

Major Shortcomings Found in Diabetes Screening at Urgent Care Centers, Study Reveals

Massive Gaps Uncovered for Diabetes Screening in Urgent Care, Research Shows UCP Merchant Medicine, the leading provider of consulting services and clinical AI technology for Urgent Care, shared data collected with their Intellivisit software revealing significant gaps in diabetes screening…

Read MoreMajor Shortcomings Found in Diabetes Screening at Urgent Care Centers, Study Reveals

Roseman University Launches Roseman Bioventures, a 120,000-Square-Foot Life Science Incubator in Las Vegas

Roseman University Launches Roseman Bioventures, a 120,000-square-foot Life Science Incubator in Las Vegas Roseman University of Health Sciences today announced the launch of Roseman Bioventures in Las Vegas to accelerate the translation of scientific breakthroughs into therapies and technologies that…

Read MoreRoseman University Launches Roseman Bioventures, a 120,000-Square-Foot Life Science Incubator in Las Vegas
Arrowhead

Element Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies

Element Science Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 Element Science, a pioneering health technology company that has developed the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) to monitor and protect high-risk cardiovascular patients from sudden…

Read MoreElement Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies
cTAP

Houston’s Rice WaTER Institute Partners with Israel’s IDE Technologies to Advance Water Treatment Innovations

Houston’s Rice WaTER Institute and Israel’s IDE Technologies Collaborate to Advance Water Treatment Solutions IDE Technologies, a world leader in desalination and advanced water treatment solutions, and Rice University’s Water Technologies Entrepreneurship and Research (WaTER) Institute, a multidisciplinary center advancing…

Read MoreHouston’s Rice WaTER Institute Partners with Israel’s IDE Technologies to Advance Water Treatment Innovations
Arrowhead

Lineage initiates a new cell therapy program targeting corneal endothelial disease.

Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced the expansion of its cell transplant pipeline…

Read MoreLineage initiates a new cell therapy program targeting corneal endothelial disease.
Novartis

Novartis to acquire Synnovation’s pan-mutant selective PI3Kα inhibitor program.

Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program Synnovation Therapeutics, LLC (“Synnovation”), a clinical-stage biotechnology company with a diverse pipeline of novel small-molecule targeted therapies in oncology and immunology today announced a definitive agreement for Novartis to acquire…

Read MoreNovartis to acquire Synnovation’s pan-mutant selective PI3Kα inhibitor program.
Pfizer

Pfizer and Valneva Report Promising Results as Lyme Disease Vaccine Candidate Shows High Efficacy in Phase 3 VALOR Trial

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial Pfizer Inc. and Valneva SE announced topline results from the Phase 3 VALOR “Vaccine Against Lyme for Outdoor Recreationists” clinical trial (NCT05477524) of its…

Read MorePfizer and Valneva Report Promising Results as Lyme Disease Vaccine Candidate Shows High Efficacy in Phase 3 VALOR Trial
Polpharma

NuScale Power and Ebara Elliott Energy partner to showcase advanced nuclear power for petrochemical plants.

NuScale Power and Ebara Elliott Energy Announce a Strategic Partnership to Showcase Use of Advanced Nuclear Technology to Power Petrochemical Plants NuScale Power Corporation the industry-leading provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology, and Ebara…

Read MoreNuScale Power and Ebara Elliott Energy partner to showcase advanced nuclear power for petrochemical plants.
ClearNote

ClearNote Health names Jeffrey Venstrom, MD, as CMO to advance early cancer test adoption.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced…

Read MoreClearNote Health names Jeffrey Venstrom, MD, as CMO to advance early cancer test adoption.